Rigel Pharmaceuticals, Inc. (RIGL)
NASDAQ: RIGL · Real-Time Price · USD
19.30
+0.02 (0.10%)
Apr 28, 2025, 9:30 AM EDT - Market open
Rigel Pharmaceuticals Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2015 - 2019 |
| Cash & Equivalents | 56.75 | 32.79 | 24.46 | 18.89 | 30.37 | Upgrade
|
| Short-Term Investments | 20.58 | 24.15 | 33.75 | 106.08 | 26.95 | Upgrade
|
| Cash & Short-Term Investments | 77.32 | 56.93 | 58.21 | 124.97 | 57.33 | Upgrade
|
| Cash Growth | 35.81% | -2.19% | -53.42% | 117.99% | -41.55% | Upgrade
|
| Receivables | 41.62 | 30.55 | 40.32 | 15.47 | 15.97 | Upgrade
|
| Inventory | 9.8 | 5.52 | 17.38 | 6.62 | 5.64 | Upgrade
|
| Prepaid Expenses | 6.37 | 6.26 | - | 7.41 | 10.05 | Upgrade
|
| Total Current Assets | 135.1 | 99.27 | 115.9 | 154.47 | 88.98 | Upgrade
|
| Property, Plant & Equipment | 0.34 | 1.03 | 2.79 | 11.89 | 20.57 | Upgrade
|
| Other Intangible Assets | 27.1 | 13.88 | 14.95 | - | - | Upgrade
|
| Other Long-Term Assets | 1.44 | 3.06 | 0.64 | 0.97 | 0.82 | Upgrade
|
| Total Assets | 163.98 | 117.23 | 134.28 | 167.33 | 110.38 | Upgrade
|
| Accounts Payable | 3.34 | 7.14 | 22.51 | 3.8 | 3.71 | Upgrade
|
| Accrued Expenses | 46.33 | 29.28 | 31.91 | 31.75 | 24.01 | Upgrade
|
| Current Portion of Long-Term Debt | 7.27 | 10.87 | 3.94 | 7.97 | - | Upgrade
|
| Current Portion of Leases | 0.29 | 0.69 | 1.13 | 9.89 | 8.62 | Upgrade
|
| Current Unearned Revenue | 1.36 | 1.36 | 1.37 | 2.6 | 3.02 | Upgrade
|
| Other Current Liabilities | 4.72 | 3.93 | 4.36 | 7.55 | 1.49 | Upgrade
|
| Total Current Liabilities | 63.3 | 53.27 | 65.21 | 63.55 | 40.84 | Upgrade
|
| Long-Term Debt | 92.39 | 92.32 | 81.71 | 72.64 | 19.82 | Upgrade
|
| Long-Term Leases | - | 0.29 | 0.97 | 0.76 | 10.65 | Upgrade
|
| Other Long-Term Liabilities | 5 | - | - | - | 5.05 | Upgrade
|
| Total Liabilities | 160.69 | 145.87 | 147.9 | 136.95 | 76.35 | Upgrade
|
| Common Stock | 0.02 | 0.02 | 0.17 | 0.17 | 0.17 | Upgrade
|
| Additional Paid-In Capital | 1,393 | 1,379 | 1,369 | 1,354 | 1,340 | Upgrade
|
| Retained Earnings | -1,390 | -1,408 | -1,382 | -1,324 | -1,306 | Upgrade
|
| Comprehensive Income & Other | 0.01 | 0.01 | -0.15 | -0.1 | -0 | Upgrade
|
| Shareholders' Equity | 3.29 | -28.64 | -13.62 | 30.37 | 34.03 | Upgrade
|
| Total Liabilities & Equity | 163.98 | 117.23 | 134.28 | 167.33 | 110.38 | Upgrade
|
| Total Debt | 99.95 | 104.17 | 87.75 | 91.27 | 39.09 | Upgrade
|
| Net Cash (Debt) | -22.63 | -47.23 | -29.55 | 33.7 | 18.24 | Upgrade
|
| Net Cash Growth | - | - | - | 84.77% | -70.47% | Upgrade
|
| Net Cash Per Share | -1.28 | -2.71 | -1.73 | 1.98 | 1.08 | Upgrade
|
| Filing Date Shares Outstanding | 17.86 | 17.54 | 17.37 | 17.17 | 17 | Upgrade
|
| Total Common Shares Outstanding | 17.71 | 17.48 | 17.34 | 17.16 | 16.93 | Upgrade
|
| Working Capital | 71.8 | 46 | 50.69 | 90.91 | 48.14 | Upgrade
|
| Book Value Per Share | 0.19 | -1.64 | -0.79 | 1.77 | 2.01 | Upgrade
|
| Tangible Book Value | -23.81 | -42.52 | -28.57 | 30.37 | 34.03 | Upgrade
|
| Tangible Book Value Per Share | -1.34 | -2.43 | -1.65 | 1.77 | 2.01 | Upgrade
|
| Machinery | 0.28 | 1.83 | 9.48 | 16.04 | 15.53 | Upgrade
|
| Construction In Progress | - | - | - | 0.69 | 0.82 | Upgrade
|
| Leasehold Improvements | - | - | 2.11 | - | - | Upgrade
|
Updated Mar 4, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.